Weiss Asset Management LP[1 »

Bluebird Bio shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Bluebird Bio (BLUE) shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Bluebird Bio

Tip: Access up to 7 years of quarterly data

All positions including Bluebird Bio held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bluebird Bio by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 750k 1.38

More positions owned by Weiss Asset Management LP[1

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Splunk Note 1.125% 9/1 (Principal)
Theravance Biopharma (TBPH)
Cytokinetics Note 3.500% 7/0 (Principal)
Tesla Motors Call Option (TSLA)
American Airls Put Option (AAL)
Nextera Energy (NEE)
Vnet Group Note 2/0 (Principal)
Atmus Filtration Technologies Ord (ATMU)
Li Auto Note 0.250% 5/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
CRH Ord Put Option (CRH)
Coinbase Global Com Cl A Put Option (COIN)
NiSource (NI)

View all positions for Weiss Asset Management LP[1

Top funds holding Bluebird Bio

Vanguard Group
Alyeska Investment Group
Norges Bank Investment Management
Millennium Management
Palo Alto Investors
Dimensional Fund Advisors
Two Sigma Investments
Bleichroeder
Citadel Advisors
Hudson Bay Capital Management
Partner Fund Management
Jpmorgan Chase & Co
Frazier Life Sciences Management
Tang Capital Management
Bank of America Corporation

View all funds holding Bluebird Bio